gopubmed logo
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 19 Aug 2016.

Insulin-like growth factor binding protein-like 1

IGFBP-l, IGFBP-rP4, IGFBPL1, insulin-like growth factor binding related protein-4
Sponsored links
Top mentioned proteins: Insulin, Insulin-Like Growth Factor I, AGE, TAF, Insulin-Like Growth Factor Binding Protein 1
Papers on IGFBP-l
IGF-I in major depression and antidepressant treatment response.
Kloiber et al., München, Germany. In Eur Neuropsychopharmacol, Jun 2015
A genetic association analysis of polymorphisms in 10 genes contributing to the IGF-I system (IGF1, IGF1R, IGFBP1 to IGFBP7, and IGFBPL1) in the currently largest genetic databases for major depression (Psychiatric Genomics Consortium) revealed nominal associations with susceptibility for depression and treatment response, although results did not remain significant after multiple testing correction.
Involvement of insulin-like growth factor-binding protein-related protein 1 in decidualization of human endometrial stromal cells.
Tamura et al., Hachiōji, Japan. In Mol Hum Reprod, 2007
These results suggest that insulin-like growth factor-binding protein-related protein 1 may play a role in decidualization of human endometrial stromal cells.
Epigenetic inactivation implies independent functions for insulin-like growth factor binding protein (IGFBP)-related protein 1 and the related IGFBPL1 in inhibiting breast cancer phenotypes.
Crook et al., London, United Kingdom. In Clin Cancer Res, 2007
Expression of IGFBPL1 is regulated by aberrant hypermethylation in breast cancer, implying that inactivation of these genes is involved in the pathogenesis of this malignancy.
Identification of a novel insulin-like growth factor binding protein gene homologue with tumor suppressor like properties.
Dedera et al., Sunnyvale, United States. In Biochem Biophys Res Commun, 2005
IGFBP-RP4 may be a novel putative tumor suppressor protein.
Circulating IGF-I and its protective role in the pathogenesis of diabetic angiopathy.
Lamberts et al., Rotterdam, Netherlands. In Clin Endocrinol (oxf), 2000
Increasing age is accompanied by a further decrease in serum IGF-I levels as well as an increase in IGFBP-l levels in adult diabetic type 1 and type 2 subjects.
Determinants of growth in diabetic pubertal subjects.
Dahlqvist et al., Sweden. In Diabetes Care, 1997
Despite decreased IGF-I levels, target final height was attained, probably because of adequate insulin compensation leading to normal IGFBP-l, thus adequate bioavailability of IGF-I.
Circulating binding proteins for the insulinlike growth factors.
Baxter, Australia. In Trends Endocrinol Metab, 1993
IGFBP-l, which is metabolically regulated by insulin and carbohydrates, may act as a counterregulator in blood glucose regulation and could also be important in targeting IGF delivery from the circulation to the tissues, while recent studies of IGFBP-2 physiology suggest that this protein may function as an additional IGF carrier when IGFBP-3 levels are inadequate.
share on facebooktweetadd +1mail to friends